Epic’s algorithms aren’t performing well in the real world, study shows
A new meta-analysis in SpringerNature shows what researchers have long said about Epic’s artificial intelligence: its out-of-
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
A new meta-analysis in SpringerNature shows what researchers have long said about Epic’s artificial intelligence: its out-of-
We are entering into the era of Navigation 2.0.
Ruth Reader here. It’s my first week at Second Opinion, and my very first introduction to our weekly roundup.
Filling the quiet gaps in chronic care—where needs are missed and patients are alone.
AI, your news of the week, and an invitation ?
“We have a truth-telling problem in US healthcare.”
Sam Toole is an entrepreneur and operator turned investor with NYC-based Primary Ventures. Since 2020, >$30Bn has flowed
The biggest deals and news of the week, plus an interview with Embold Health president and founder Daniel Stein
Cardiology is a hotbed for where these deep learning tools can shine.